/Investors

Mekong Capital — 2025 Investments

3 investments dated 2025 · listed companies and verified rows first · show all

LiveSpolivespo.cominOct 2025✓ verified

LiveSpo develops spore probiotic products and technologies designed to promote gut health and reduce reliance on antibiotics.

BiotechConsumerHealthtechMedical DevicesWellness & FitnessHanoi, VN

Dr. Nguyen Hoa Anhin

Gene Solutionsgenesolutions.cominSep 2025

Gene Solutions is a biotechnology company that develops genetic testing solutions using Next-Generation Sequencing and artificial intelligence for reproductive health, clinical oncology, and multi-cancer screening.

AI & Machine LearningBiotechDigital HealthMedical DevicesThailand, TH

W. Davis Parker, Jr.(Executive Officer, Director)Brian Warrington(Executive Officer, Director)Edward P. Connell(Executive Officer, Director)Susan D. Jones(Executive Officer, Director)David B. Patteson(Executive Officer, Director)

BoardJames Oury(Director)

Maroumarouchocolate.comin𝕏Oct 2025

Marou Faiseurs de Chocolat is a bean-to-bar chocolate maker that sources premium cocoa beans directly from small farmers across Vietnamese provinces and produces craft dark chocolate entirely from Vietnamese-grown ingredients.

ConsumerDirect to ConsumerFoodTechSaigon, VN

Samuel MarutaVincent Mourou

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.